Upgrade to see committee overlap, performance context, and full expert analysis.
IEF congressional trades
8 matched disclosures
IEF congressional trades snapshot
This page summarizes public STOCK Act disclosures involving IEF. It is useful for seeing which lawmakers reported IEF transactions, how many filings are visible, the buy/sell mix, and whether the newest public filing describes a recent or delayed trade.
Jun 16, 2026
Public House and Senate STOCK Act disclosures normalized by Congressional Trader.
Filing date can trail transaction date. This page is for research and monitoring, not investment advice.
What the IEF congressional trade page shows
Congressional Trader tracks 8 public STOCK Act disclosures for IEFacross 1 lawmakers. This page separates purchases from sales, shows filing delays, and links each disclosure back to the individual politician profile when available.
The most recent IEF filing shown here was filed on Jun 16, 2026 by John Boozman as a purchase. Related lawmakers include John Boozman.
Top lawmakers for IEF
Pro performance summary
Unlock 30/90-day post-trade summaries, committee overlap, and CSV-oriented research views for high-intent ticker research.
Compare Pro plansUpgrade to see committee overlap, performance context, and full expert analysis.
Upgrade to see committee overlap, performance context, and full expert analysis.
Upgrade to see committee overlap, performance context, and full expert analysis.
Upgrade to see committee overlap, performance context, and full expert analysis.
Upgrade to see committee overlap, performance context, and full expert analysis.
Upgrade to see committee overlap, performance context, and full expert analysis.
Upgrade to see committee overlap, performance context, and full expert analysis.
FAQ
Which lawmakers traded IEF?
Recent IEF disclosures include John Boozman.
What is the buy/sell mix for IEF?
The visible sample currently shows 6 purchases and 2 sales or partial sales.
Should I trade based on IEF disclosures?
No. This page summarizes public filings for research and monitoring. It is not investment advice.